In this article, I describe a command, ipdmetan, that facilitates two-stage individual participant data meta-analysis of any measure of effect and its standard error by fitting a specified model to data from each study. The command can estimate random effects and heterogeneity statistics and include additional covariates and interactions. If individual participant data are available for certain studies and aggregate data for others, ipdmetan allows them to be combined in one analysis. This command can produce detailed and flexible forest plots, including ones outside the context of formal meta-analysis.
BiggerstaffB. J., and TweedieR. L.1997. Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Statistics in Medicine16: 753–768.
2.
BowdenJ., TierneyJ. F., SimmondsM., CopasA. J., and HigginsJ. P. T.2011. Individual patient data meta-analysis of time-to-event outcomes: One-stage versus two-stage approaches for estimating the hazard ratio under a random effects model. Research Synthesis Methods2: 150–162.
3.
BurdettS., RydzewskaL., TierneyJ. F., FisherD. J., and PORT Meta-analysis Trialist Group. 2013. A closer look at the effects of postoperative radiotherapy by stage and nodal status: Updated results of an individual participant data meta-analysis in non-small-cell lung cancer. Lung Cancer80: 350–352.
4.
BurdettS., StewartL., and PORT Meta-analysis Group. 2005. Postoperative radiotherapy in non-small-cell lung cancer: Update of an individual patient data meta-analysis. Lung Cancer47: 81–83.
5.
CrowtherM. J., LookM. P., and RileyR. D.2014. Multilevel mixed effects parametric survival models using adaptive Gauss–Hermite quadrature with application to recurrent events and individual participant data meta-analysis. Statistics in Medicine33: 3844–3858.
6.
DeeksJ. J., AltmanD. G., and BradburnM. J.2001. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In Systematic Reviews in Health Care: Meta-analysis in Context, ed. EggerM., Davey SmithG., and AltmanD. G., 2nd ed., 285–312. London: BMJ Books.
7.
DerSimonianR., and KackerR.2007. Random-effects model for meta-analysis of clinical trials: An update. Contemporary Clinical Trials28: 105–114.
8.
DerSimonianR., and LairdN.1986. Meta-analysis in clinical trials. Controlled Clinical Trials7: 177–188.
9.
FisherD. J., CopasA. J., TierneyJ. F., and ParmarM. K. B.2011. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. Journal of Clinical Epidemiology64: 949–967.
10.
HarbordR. M., and HigginsJ. P. T.2008. Meta-regression in Stata. Stata Journal8: 493–519.
11.
HardyR. J., and ThompsonS. G.1996. A likelihood approach to meta-analysis with random effects. Statistics in Medicine15: 619–629.
12.
HarrisR. J., BradburnM. J., DeeksJ. J., HarbordR. M., AltmanD. G., and SterneJ. A. C.2008. metan: Fixed- and random-effects meta-analysis. Stata Journal8: 3–28.
13.
HartungJ., and KnappG.2001. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Statistics in Medicine20: 3875–3889.
14.
HigginsJ. P. T., and GreenS.2011. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0.http://www.cochrane-handbook.org.
15.
HigginsJ. P. T., and ThompsonS. G.2002. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine21: 1539–1558.
16.
JannB.2005. moremata: Stata module (Mata) to provide various functions. Statistical Software Components S455001, Department of Economics, Boston College.https://ideas.repec.org/c/boc/bocode/s455001.html.
17.
KontopantelisE., and ReevesD.2010. metaan: Random-effects meta-analysis. Stata Journal10: 395–407.
18.
KontopantelisE., and ReevesD.2012. Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study. Statistical Methods in Medical Research21: 409–426.
19.
KontopantelisE., and ReevesD.2013. A short guide and a forest plot command (ipdforest) for one-stage meta-analysis. Stata Journal13: 574–587.
20.
KontopantelisE., SpringateD. A., and ReevesD.2013. A re-analysis of the Cochrane Library data: The dangers of unobserved heterogeneity in meta-analyses. PLOS ONE8: e69930.
21.
ManderA.2012. integrate: Stata module to perform one-dimensional integration. Statistical Software Components S457429, Department of Economics, Boston College.https://ideas.repec.org/c/boc/bocode/s457429.html.
22.
MathewT., and NordströmK.2010. Comparison of one-step and two-step meta-analysis models using individual patient data. Biometrical Journal52: 271–287.
23.
MittlböckM., and HeinzlH.2006. A simulation study comparing properties of heterogeneity measures in meta-analyses. Statistics in Medicine25: 4321–4333.
24.
RileyR. D., LambertP. C., StaessenJ. A., WangJ., GueyffierF., ThijsL., and BoutitieF.2008. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Statistics in Medicine27: 1870–1893.
25.
RoystonP., and AltmanD. G.1994. Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling (with discussion). Journal of the Royal Statistical Society, Series C43: 429–467.
26.
RukhinA. L.2013. Estimating heterogeneity variance in meta-analysis. Journal of the Royal Statistical Society, Series B75: 451–469.
27.
SidikK., and JonkmanJ. N.2002. A simple confidence interval for meta-analysis. Statistics in Medicine21: 3153–3159.
28.
SidikK., and JonkmanJ. N.2007. A comparison of heterogeneity variance estimators in combining results of studies. Statistics in Medicine26: 1964–1981.
29.
SimmondsM. C., and HigginsJ. P. T.2007. Covariate heterogeneity in meta-analysis: Criteria for deciding between meta-regression and individual patient data. Statistics in Medicine26: 2982–2999.
30.
SimmondsM. C., HigginsJ. P. T., StewartL. A., TierneyJ. F., ClarkeM. J., and ThompsonS. G.2005. Meta-analysis of individual patient data from randomized trials: A review of methods used in practice. Clinical Trials2: 209–217.
31.
SterneJ. A. C., ed. 2009. Meta-Analysis in Stata: An Updated Collection from the Stata Journal.College Station, TX: Stata Press.
32.
StewartG. B., AltmanD. G., AskieL. M., DuleyL., SimmondsM. C., and StewartL. A.2012. Statistical analysis of individual participant data meta-analyses: A comparison of methods and recommendations for practice. PLOS ONE7: e46042.
33.
StewartL. A., and TierneyJ. F.2002. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Evaluation and the Health Professions25: 76–97.
34.
Tudur SmithC., and WilliamsonP. R.2007. A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes. Clinical Trials4: 621–630.
35.
ViechtbauerW.2007. Confidence intervals for the amount of heterogeneity in meta-analysis. Statistics in Medicine26: 37–52.
36.
WhiteI. R.2009. Multivariate random-effects meta-analysis. Stata Journal9: 40–56.
37.
YusufS., PetoR., LewisJ., CollinsR., and SleightP.1985. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progress in Cardiovascular Diseases27: 335–371.
